Cabaletta Bio Stock Alpha and Beta Analysis

CABA Stock  USD 2.42  0.13  5.68%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cabaletta Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cabaletta Bio over a specified time horizon. Remember, high Cabaletta Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cabaletta Bio's market risk premium analysis include:
Beta
3.84
Alpha
(1.70)
Risk
7.06
Sharpe Ratio
(0.16)
Expected Return
(1.13)
Please note that although Cabaletta Bio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Cabaletta Bio did 1.70  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Cabaletta Bio stock's relative risk over its benchmark. Cabaletta Bio has a beta of 3.84  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cabaletta Bio will likely underperform. At present, Cabaletta Bio's Book Value Per Share is projected to slightly grow based on the last few years of reporting. The current year's Tangible Book Value Per Share is expected to grow to 6.06, whereas Enterprise Value Over EBITDA is projected to grow to (9.62).

Enterprise Value

153.24 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Cabaletta Bio Backtesting, Cabaletta Bio Valuation, Cabaletta Bio Correlation, Cabaletta Bio Hype Analysis, Cabaletta Bio Volatility, Cabaletta Bio History and analyze Cabaletta Bio Performance.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

Cabaletta Bio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cabaletta Bio market risk premium is the additional return an investor will receive from holding Cabaletta Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cabaletta Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cabaletta Bio's performance over market.
α-1.7   β3.84

Cabaletta Bio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cabaletta Bio's Buy-and-hold return. Our buy-and-hold chart shows how Cabaletta Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Cabaletta Bio Market Price Analysis

Market price analysis indicators help investors to evaluate how Cabaletta Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cabaletta Bio shares will generate the highest return on investment. By understating and applying Cabaletta Bio stock market price indicators, traders can identify Cabaletta Bio position entry and exit signals to maximize returns.

Cabaletta Bio Return and Market Media

The median price of Cabaletta Bio for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 is 4.26 with a coefficient of variation of 20.12. The daily time series for the period is distributed with a sample standard deviation of 0.85, arithmetic mean of 4.23, and mean deviation of 0.56. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 258456 shares by 5am Ventures V, L.p. of Cabaletta Bio at 13.0 subject to Rule 16b-3
09/06/2024
2
Disposition of 11000 shares by Gwendolyn Binder of Cabaletta Bio at 1.01 subject to Rule 16b-3
09/13/2024
3
Lynx1 Capital Management LP Lowers Stock Position in Cabaletta Bio, Inc. - MarketBeat
09/27/2024
4
Acquisition by Nichtberger Steven of 333500 shares of Cabaletta Bio at 11.47 subject to Rule 16b-3
10/04/2024
5
State Street Corps Strategic Reduction in Cabaletta Bio Inc Holdings
10/17/2024
6
Were Not Very Worried About Cabaletta Bios Cash Burn Rate - Yahoo Finance
10/30/2024
7
Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
11/14/2024
8
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
11/18/2024
9
Acquisition by Simon Mark of 7000 shares of Cabaletta Bio at 0.9764 subject to Rule 16b-3
11/20/2024
10
Cabaletta Bios SWOT analysis CAR-T pioneers stock faces pivotal moment - Investing.com
11/21/2024

About Cabaletta Bio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cabaletta or other stocks. Alpha measures the amount that position in Cabaletta Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Cabaletta Bio Upcoming Company Events

As portrayed in its financial statements, the presentation of Cabaletta Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cabaletta Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cabaletta Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cabaletta Bio. Please utilize our Beneish M Score to check the likelihood of Cabaletta Bio's management manipulating its earnings.
21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Cabaletta Bio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:
Cabaletta Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cabaletta Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cabaletta Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...